Indian industry contributing to COVID19 Candidate Drugs

COMPANY vs DRUG CHART

Click on image to see full image!

DRUGS > Highlights

  • 29  drug candidates studied by TFORD to date
  • 21 out of 29 have existing Indian suppliers; Some others have upcoming potential suppliers. 

Summary: India is strongly positioned to respond to the COVID19 related requirements (if any)  of repurposed drugs both for India’s needs and the World’s!

HERBS > HIGHLIGHTS

  • 9 medicinal herb candidates studied by TFORD
  • 9 out of 9  have Indian suppliers

Summary: If herbs are found to be effective for COVID19 prophylaxis or treatment, Indian companies  are  positioned strongly to contribute to National and Global needs.